Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): A Randomised Placebo-Controlled Trial

NCT04939935 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT04939935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04939935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD): A Randomised Placebo-Controlled Trial
Lead sponsor
The University of Queensland
Phase
Phase 3
Overall status
Recruiting
Start date
November 29, 2022
Completion date
December 31, 2030
Enrollment
1,174 (estimated)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney disease